Skip to content
Saturday 5 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,831.09
0.00%
DAX
26,046.40
+0.17%
CAC 40
8,278.77
-0.09%
STOXX 50
6,392.93
+0.16%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 11 December 2013 7:27 pm

Failing UK drugs policy should take a leaf from Uruguay and Portugal

By: Express KCS

Add as a preferred source on Google

DRUGS are harmful, whether they are legal or illegal. The challenge is how to reduce the harms they cause. For decades, countries have tried to stop drug use by handing out criminal justice sanctions. People are arrested, tried, and convicted, at vast expense. But this has not stopped the ready availability of a huge range of drugs.

The harms from drug use continue when they are prohibited, but extra harms are created, with the rise of cartels, narco-terrorism and all the other consequences of driving the trade underground. Products are contaminated, and people often don’t know what they are getting. Prohibition hasn’t reduced harm – it’s increased it.

Yet some countries are prepared to look for a better way. Portugal has decriminalised possession, while still targeting dealers. Addicts get treatment and support, rather than the risk of jail, and money is diverted from courts and prisons to healthcare and rehabilitation. As a result, the country has cut usage and got more people into treatment. On a visit to Portugal with the Home Affairs Select Committee, as part of our study into drugs policy, we could not find anyone opposed to this approach, from politicians to police.

Latin American countries like Colombia have suffered more than most from the international “war on drugs”, ravaged by cartels fighting for their share of the hugely-inflated profits available from illicit drugs. The trafficking of drugs from South America to the US alone is worth an estimated $13bn (£9.7bn) a year. Latin American civilians are paying the cost of our failure to have a more sensible approach to drugs policy. These countries have urged global leaders to think again, and now they have taken action into their own hands.

Yesterday, Uruguay passed a historic law that makes it legal to grow, sell and buy marijuana. It’s the first country to make such a bold move, although two US states, Washington and Colorado, took the same step last year. Will it work? Time will tell – and we should watch carefully.

Crucially, however, none of these places is suggesting a free-for-all. But tightly-regulated sales are safer for people than back-alley deals. Transform, the respected drugs policy foundation, has just published How to Regulate Cannabis: A Practical Guide. This excellent and detailed book explains how best to control cannabis sales, in a legalised market, with a focus on harm reduction. It has received praise from many, including Uruguay’s President and professor David Nutt, the former UK drugs adviser.

What hope is there for Britain’s drugs policy? Will we continue to clog up our courts system with drug addicts who need help, or should we look and learn from innovative countries like Portugal and Uruguay?

There are some glimmers of hope. Nick Clegg backed the cross-party Home Affairs Select Committee’s call for a Royal Commission to look into a more sensible drugs policy. The Lib Dem ministers in the Home Office, first Jeremy Browne and now Norman Baker, are conducting an international comparative review into drugs policy – the first of its kind. I just hope the Home Secretary will allow them to publish their findings unedited!

Dr Julian Huppert is Liberal Democrat MP for Cambridge.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Opinion

Categories

  • Opinion

Trending Articles

  • Victoria Beckham owed £350,000 by Harvey Nichols

  • M&G: FTSE 100 giant hits out at Rayner’s ground rent cap as it suffers loss

  • Fulham owner Khan sees his £1bn stadium construction project take next steps

  • John Lewis boss: UK economy facing a ‘permacrisis’ 

  • Don’t underestimate the free trade agreement Britain just joined

More from Morning Wire

  • Whey and weight-loss drugs to eat into Applied Nutrition profit

    Retail
    Woman lifting dumbbells with a trainer in a busy gym, promoting fitness and health
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Luis Figo: ‘Deceitful and cravenly self-interested’ Infantino must quit Fifa now

    Sport Business
    Gianni Infantino and Luís Figo smiling, walking outdoors with security, on a wet day.
  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
  • The Debate: should we release female prisoners to make space for men?

    Opinion
    Brick prison wall with barred windows, razor wire, and a security camera.
  • euroAtlantic Airways Expands Long-Haul Fleet With a New Airbus A330-300 Aircraft

    Business Wire
  • ‘Absurd’: Government seeks quantum tech chief – no experience necessary

    Tech
    Advanced quantum computer with intricate circuits and glowing interface, illustrating cutting-edge technology innovations
  • Revolut lands fresh banking licence after wrestling with Europe friction

    Fintech
    Revolut Banque Française ad on a Morris column in Paris, with the July Column and blurred traffic in the background.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook